FR2940087B1 - Erythrocytes contenant du facteur viii, preparation et utilisations. - Google Patents

Erythrocytes contenant du facteur viii, preparation et utilisations.

Info

Publication number
FR2940087B1
FR2940087B1 FR0858777A FR0858777A FR2940087B1 FR 2940087 B1 FR2940087 B1 FR 2940087B1 FR 0858777 A FR0858777 A FR 0858777A FR 0858777 A FR0858777 A FR 0858777A FR 2940087 B1 FR2940087 B1 FR 2940087B1
Authority
FR
France
Prior art keywords
preparation
factor viii
containing factor
erythrocytes containing
erythrocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0858777A
Other languages
English (en)
Other versions
FR2940087A1 (fr
Inventor
Jean Francois Prost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LFB SA filed Critical LFB SA
Priority to FR0858777A priority Critical patent/FR2940087B1/fr
Priority to PCT/FR2009/052608 priority patent/WO2010076517A1/fr
Publication of FR2940087A1 publication Critical patent/FR2940087A1/fr
Application granted granted Critical
Publication of FR2940087B1 publication Critical patent/FR2940087B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0858777A 2008-12-18 2008-12-18 Erythrocytes contenant du facteur viii, preparation et utilisations. Expired - Fee Related FR2940087B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0858777A FR2940087B1 (fr) 2008-12-18 2008-12-18 Erythrocytes contenant du facteur viii, preparation et utilisations.
PCT/FR2009/052608 WO2010076517A1 (fr) 2008-12-18 2009-12-18 Érythrocytes contenant du facteur viii, préparation et utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0858777A FR2940087B1 (fr) 2008-12-18 2008-12-18 Erythrocytes contenant du facteur viii, preparation et utilisations.

Publications (2)

Publication Number Publication Date
FR2940087A1 FR2940087A1 (fr) 2010-06-25
FR2940087B1 true FR2940087B1 (fr) 2011-05-06

Family

ID=40636702

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0858777A Expired - Fee Related FR2940087B1 (fr) 2008-12-18 2008-12-18 Erythrocytes contenant du facteur viii, preparation et utilisations.

Country Status (2)

Country Link
FR (1) FR2940087B1 (fr)
WO (1) WO2010076517A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6017422B2 (ja) 2010-08-10 2016-11-02 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） 赤血球結合療法
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
KR20240154672A (ko) 2014-02-21 2024-10-25 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) 글리코타겟팅 치료제
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3638296A1 (fr) 2017-06-16 2020-04-22 The University Of Chicago Compositions et procédés d'induction d'une tolérance immunitaire
SG11202011078VA (en) 2018-05-09 2020-12-30 Univ Chicago Compositions and methods concerning immune tolerance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529463B1 (fr) 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
FR2678512B1 (fr) 1991-07-03 1995-06-30 Novacell Machine a internaliser.
DE69732225T2 (de) 1997-05-05 2005-06-23 Dideco S.R.L., Mirandola Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
FR2873925B1 (fr) 2004-08-05 2006-10-13 Erytech Pharma Soc Par Actions Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
FR2884717B1 (fr) 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
FR2891843A1 (fr) 2005-10-06 2007-04-13 Erytech Pharma Soc Par Actions Erythrocytes contenant du 5-fluorouracile
WO2007097934A2 (fr) * 2006-02-17 2007-08-30 Elusys Therapeutics, Inc. Procédés et compositions permettant d'utiliser des érythrocytes comme véhicules de délivrance de médicaments

Also Published As

Publication number Publication date
FR2940087A1 (fr) 2010-06-25
WO2010076517A1 (fr) 2010-07-08

Similar Documents

Publication Publication Date Title
IL230076A0 (en) Certain chemical entities, compositions and methods
FR2941231B1 (fr) Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
BRPI0911351A2 (pt) estrutura de sent, e , prótese de válvula.
BRPI0815773A2 (pt) composto, e, medicamento.
BRPI0923823A2 (pt) Agente de colaboração.
PL3653173T3 (pl) Niskoprofilowa przezcewnikowa zastawka serca
NO2021006I1 (no) Quofenix, delafloksacin
HRP20151058T1 (xx) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
ATE540040T1 (de) Dioxabicycloä3.2.1üoctan-2,3,4-triolderivate
BRPI0807473A2 (pt) Recipiente, javre e conjunto de recipiente e javre
BRPI0923231A2 (pt) anticorpo anti-cmet.
BRPI0917120A2 (pt) método, e, meio legível por computador.
EP2064335A4 (fr) Molécules ayant des demi-vies réduites, compositions et leurs utilisations
BRPI0909084A2 (pt) Composição líquida, e, composto de peptídeo.
HRP20150107T1 (xx) Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola
BRPI0913112A2 (pt) fluxímetro, e, método.
EP2370573A4 (fr) Endoglucanases fongiques, production et utilisation
BRPI0815922A2 (pt) Artigo, composição, e, método.
CL2008000689S1 (es) Protesis mamaria.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI0914584A2 (pt) Método, e, composição herbicida.
JP2013541099A5 (fr)
CR10526S (es) Contenedor
CL2008000943S1 (es) Contenedor transparente.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829